Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 29.5 | 17.1 | 12.5 | 14.2 | 12.5 | 10.8 | 10.3 | 9.9 |
| Revenue growth | 72.1% | 36.9% | -11.9% | 13.8% | 15.7% | 4.6% | 3.8% | 3.6% |
| Cost of goods sold | 20.8 | 11.1 | 9.9 | 10.9 | 8.6 | 7.5 | 7.2 | 7.1 |
| Gross profit | 8.7 | 6.0 | 2.6 | 3.3 | 3.9 | 3.2 | 3.1 | 2.8 |
| Gross margin | 29.5% | 35.0% | 20.9% | 23.2% | 30.9% | 30.0% | 30.2% | 28.5% |
| Selling, general and administrative | 8.7 | 8.4 | 3.5 | 8.1 | 2.9 | 3.0 | 3.0 | 3.2 |
| Research and development | 2.2 | 1.6 | 1.9 | 2.1 | 1.7 | 1.6 | 1.3 | 1.3 |
| General and administrative | 0.9 | 2.5 | | 1.6 | | | | |
| EBIT | 2.6 | 1.5 | -2.8 | -2.0 | -0.8 | -1.3 | -1.2 | -1.7 |
| EBIT margin | 8.7% | 8.7% | -22.4% | -14.3% | -6.2% | -12.3% | -11.4% | -17.3% |
| Pre-tax income | 2.4 | 1.0 | -3.0 | -2.1 | -0.8 | -1.3 | -1.2 | -1.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 1.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | 2.3 | 1.0 | -3.0 | -2.1 | -0.8 | -1.3 | -1.2 | -1.7 |
| Net margin | 7.9% | 5.8% | -24.0% | -14.7% | -6.3% | -11.9% | -11.6% | -17.4% |
| |
| Diluted EPS | $0.05 | $0.03 | ($0.08) | ($0.06) | ($0.03) | ($0.04) | ($0.04) | ($0.06) |
| Shares outstanding (diluted) | 47.0 | 38.5 | 36.6 | 33.9 | 31.3 | 30.9 | 28.6 | 28.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|